Long-term Course of Alzheimer Disease in Patients Treated According to the Dutch Dementia Guideline at a Memory Clinic
Authors:
- Dieneke van AsseltDADieneke van Asselt
- Jolanda van SteijnJSJolanda van Steijn
- Marjolein DiekhuisMDMarjolein Diekhuis
- Nic VeegerNVNic Veeger
- Peter P. De DeynPDPeter P. De Deyn
- 1 January 2016
- journal article
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 30 (1) , 53-59
Abstract
There is little knowledge of the long-term course of Alzheimer disease (AD) in light of current pharmacological and nonpharmacological interventions provided in a "real-life" setting.The Frisian Alzheimer's Disease Cohort study is a "real-life" study of the course of AD in patients (n=576) treated with pharmacological (ie, cholinesterase inhibitors) and nonpharmacological (ie, case management, respite care) interventions. Disease course was described by changes in cognition (Mini Mental State Examination, clock-drawing test) and number of types of professional care applying a repeated-measures analysis using a marginal model (population-based average model). In addition, behavioral and psychological symptoms, and proportions of nursing home admissions and deaths were investigated.During 3.5 years, the average Mini Mental State Examination decreased from 22.24 to 18.91, the clock-drawing test score increased from 3.38 to 4.05, the number of types of professional care increased from 0.85 to 2.64, and the patients with behavioral and psychological symptoms increased from 29.0% to 70.2%. The proportion of patients admitted to a nursing home was 40.8% and 41.0% died.Cognition and behaviour of AD patients deteriorated accompanied with an increase in care-dependency during 3.5 years. Nevertheless, compared with the precholinesterase inhibitor era, current pharmacological and nonpharmacological interventions appear to slow cognitive decline, which emphasizes that they seem to have a favorable effect.Keywords
This publication has 27 references indexed in Scilit:
- A longitudinal study of risk factors for community-based home help services in Alzheimer’s disease: the influence of cholinesterase inhibitor therapyClinical Interventions in Aging, 2013
- Cholinesterase inhibitors and memantine for symptomatic treatment of dementiaBMJ, 2012
- Epidemiology of Alzheimer diseaseNature Reviews Neurology, 2011
- Quality of Life and Burden of Spouses of Alzheimer Disease PatientsAlzheimer Disease & Associated Disorders, 2009
- Alzheimer's diseaseBMJ, 2009
- A Manual of Guidelines to Score the Modified Cumulative Illness Rating Scale and Its Validation in Acute Hospitalized Elderly PatientsJournal of the American Geriatrics Society, 2008
- Tracking Cognitive Decline in Alzheimer's Disease Using the Mini-Mental State Examination: A Meta-AnalysisInternational Psychogeriatrics, 2000
- Clock‐drawing and dementia in the community: A longitudinal studyInternational Journal of Geriatric Psychiatry, 1993
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- “Mini-mental state”Journal of Psychiatric Research, 1975